Loading...
Loading...
Browse all stories on DeepNewz
VisitLeading Global Regions in Utilizing AlphaFold 3 for Drug Discovery by 2024
North America • 25%
Europe • 25%
Asia • 25%
Rest of the World • 25%
Global health and pharmaceutical industry reports
Google and Isomorphic Labs Unveil AlphaFold 3, Expanding AI in Drug Discovery
May 12, 2024, 05:36 PM
Google, in collaboration with Isomorphic Labs, has launched AlphaFold 3, an advanced AI model developed by Google DeepMind. This new iteration significantly expands its capabilities beyond its predecessor, AlphaFold 2, by predicting not only protein structures but also the 3D structures and interactions of all biomolecules, including DNA, RNA, and ligands. This breakthrough is expected to revolutionize AI-driven drug discovery and provide insights into a vast universe of biomolecules.
View original story
North America • 25%
Europe • 25%
Asia • 25%
Rest of the World • 25%
Drug discovery • 25%
Genetic research • 25%
Cancer research • 25%
Antibody development • 25%
Pharmaceuticals • 20%
Biotechnology • 20%
Cosmetics • 20%
Food and Beverage • 20%
Agriculture • 20%
Pharmaceuticals • 33%
Biotechnology • 33%
Academic Research • 34%
Bioinformatics • 33%
Agricultural Genetics • 33%
Environmental Science • 34%
Under 100 • 25%
100-500 • 25%
501-1000 • 25%
Over 1000 • 25%
No Change or Decrease • 50%
Increase • 50%
Moderately Adopted • 34%
Widely Adopted • 33%
Rarely Adopted • 33%